Capital Research & Management Co. (World Investors)

Capital Research & Management Co. (World Investors)

Capital Research & Management Co. (World Investors)

Date Founded



333 South Hope Street,53rd floor,Los Angeles, CA 90071-3061

Type of Company



Investment Services & Portfolio Management

Company Description

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm utilizes fundamental research to gather in-depth information on markets and companies around the world. They also employ a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Contact Data
Trying to get in touch with decision makers at Capital Research & Management Co. (World Investors)? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Partner & Investment Analyst

Partner, Portfolio Manager & Analyst

Partner & Investment Analyst

Co-Head of Global Investment Group


Investment Analyst & Portfolio Manager

Portfolio Manager & Investment Analyst

Paths to Capital Research & Management Co. (World Investors)
Potential Connections via
Relationship Science
Capital Research & Management Co. (World Investors)
Recent Transactions
Details Hidden

Harris Associates LP, Southeastern Asset Management, Inc., Dodge & Cox, Inc., Provide Commerce, Inc., Qurate Retail, Inc., ClearBridge Investments LLC, Capital Research & Management Co. (World Investors), Capital Research & Management Co. (Global Investors) purchase RedEnvelope, Inc.

Details Hidden

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. Mepsevii is an intravenous, which is used for the treatment of Mucopolysaccharidosis VII. Crysvita is an antibody administered via subcutaneous injection used for the treatment of XLH. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

Details Hidden

Novatel Wireless, Inc. engages in the provision of solutions for the Internet of Things (IoT). It offers communications and analytics for consumers and businesses of industries including vehicle fleet management and telematics, connected retail systems, government, home security, and other connected life scenarios. The company was founded by Horst Julius Pudwill on April 26, 1996 and is headquartered in San Diego, CA.

Details Hidden

ExteNet Systems, Inc. owns, manages and operates indoor and outdoor distributed networks. It offers node and fiber network monitoring, base transceiver station hub security monitoring, advanced remote diagnostics, network event notification and resolution, trouble ticketing, scheduled maintenance, and network health reporting services. The company was founded by Ross W. Manire and Eric Lekacz in 2002 and is headquartered in Lisle, IL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Capital Research & Management Co. (World Investors). The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Capital Research & Management Co. (World Investors)'s profile does not indicate a business or promotional relationship of any kind between RelSci and Capital Research & Management Co. (World Investors).